BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Center for RNA Biomedicine - ECPv6.15.17//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://rna.umich.edu
X-WR-CALDESC:Events for Center for RNA Biomedicine
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Detroit
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Detroit:20221219T120000
DTEND;TZID=America/Detroit:20221219T130000
DTSTAMP:20260403T155120
CREATED:20221118T154320Z
LAST-MODIFIED:20221220T131454Z
UID:10695-1671451200-1671454800@rna.umich.edu
SUMMARY:RNA Therapeutics Seminar: Melissa Moore\, CSO\, Moderna Therapeutics\, Emerita
DESCRIPTION:“The Science Behind mRNA Medicines: COVID-19 Vaccines and Beyond”\nMelissa J. Moore\, Ph.D.\nChief Scientific Officer\, Moderna Therapeutics\, Emerita\nIn-person: BSRB\, Kahn Auditorium and hybrid. Here is the link for the seminar video. \nDr. Moore will be awarded an honorary degree at the University of Michigan Ann Arbor campus’ 2022 Winter Commencement and give this scientific talk to our RNA community. \n  \n  \nBiography: From 2016-2021\, Dr. Moore led the early-stage research teams developing Moderna’s platform technologies in mRNA design and delivery. These technologies were foundational for Moderna’s ability to rapidly create a highly effective vaccine against SARS-CoV-2. As CSO\, Emerita\, she now focuses on explaining the science behind mRNA medicines. During her 23 years as faculty member\, first at Brandeis University (1994-2007) and then at the University of Massachusetts Medical School (2007-2016)\, her research encompassed a broad array of topics related to the roles of RNA and RNA-protein (RNP) complexes in gene expression\, and touched on many human diseases including cancer\, neurodegeneration and preeclampsia. A long-time Investigator at the Howard Hughes Medical Institute (HHMI)\, Dr. Moore is an elected member of the National Academy of Sciences (2017)\, a Fellow of the American Academy of Arts and Sciences (2019)\, and recipient of the RNA Society Lifetime Achievement Award (2021).\nDr. Moore holds a B.S. in Chemistry and Biology from the College of William and Mary\, and a Ph.D. in Biological Chemistry from MIT\, where she specialized in enzymology under Prof. Christopher T. Walsh. She bean working on RNA metabolism during her postdoctoral training with Philip A. Sharp at MIT. Her passions include educating the public about the coming age of nucleic acid medicines and increasing Diversity\, Equality and Inclusion (DEI) at all levels of the biotechnology workforce.
URL:https://rna.umich.edu/events/melissa-moore-2022/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Detroit:20221219T160000
DTEND;TZID=America/Detroit:20221219T170000
DTSTAMP:20260403T155120
CREATED:20220902T193934Z
LAST-MODIFIED:20221219T204928Z
UID:10579-1671465600-1671469200@rna.umich.edu
SUMMARY:RNA Innovation Seminar: Hayley McLoughlin\, Neurology
DESCRIPTION:“Antisense Oligonucleotides for Ataxia”\nHayley McLoughlin\, Ph.D.\nAssistant Professor of Neurology\nAssistant Professor of Human Genetics\nUniversity of Michigan \n  \n  \nIn-person: BSRB\, ABC seminar rooms / hybrid link \nAbstract: Her talk will cover recent advances in antisense oligonucleotide (ASO) therapy with a particular emphasis towards their mechanistic and therapeutic applications in Ataxia. She will specifically discuss ASO approaches in the most common dominantly inherited ataxia\, Spinocerebellar ataxia type (SCA3). SCA3 is one of nine polyglutamine expansion diseases and is caused by a gain-of-function repeat expansion in the disease gene\, ATXN3. To date\, there is no effective treatment for this relentlessly progressive and fatal neurodegenerative disease. Throughout her postdoctoral training in Dr. Paulson’s lab and into her independent research career\, she has assessed the efficacy and tolerability of anti-ATXN3 ASO gene silencing therapy in SCA3 mouse models in collaboration with Ionis Pharmaceuticals. Published in successive cross-sectional (PMC5415970) and longitudinal studies (PMC6119475)\, they defined the first evidence of a gene therapy mitigating both pathological and behavioral disease phenotypes in the SCA3 mouse\, which overexpresses the full-length human disease gene. These anti-ATXN3 ASOs are currently begin assessed in SCA3 human subjects through a Phase 1 clinical trial driven by Biogen for pharmacokinetics and safety (ClinicalTrials.gov Identifier: NCT05160558).
URL:https://rna.umich.edu/events/hayley-mcloughlin/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Detroit:20230109T160000
DTEND;TZID=America/Detroit:20230109T170000
DTSTAMP:20260403T155120
CREATED:20220902T192057Z
LAST-MODIFIED:20230109T135614Z
UID:10565-1673280000-1673283600@rna.umich.edu
SUMMARY:RNA Innovation Seminar: Karen Mohlke\, UNC
DESCRIPTION:“Genetic Variant Effects on Adipose Gene Expression and Their Role in Cardiometabolic Traits.”\nKaren Mohlke\, Ph.D.\nProfessor and Associate Chair for Research\nOliver Smithies Investigator\nDepartment of Genetics\, University of North Carolina\nIn-person: BSRB\, ABC seminar rooms / hybrid link \nAbstract: Noncoding genetic variants can affect common diseases and related quantitative traits. Variants may affect the expression levels of transcripts and alternatively-spliced isoforms\, dependent on cell context. I will describe genetic variants associated with adipose tissue gene expression level in >2\,200 people and their putative roles in cardiometabolic disease traits. Similarly\, I will implicate variants associated with splice junction usage in disease risk. Finally\, based on chromatin accessibility during adipocyte differentiation\, I will show genetic regulatory effects that depend on cell context. Together\, these studies help identify regulatory mechanisms for common diseases.\nKeywords: Transcriptome\, expression quantitative trait loci (eQTL)\, splice QTL (sQTL)\, genome-wide association study (GWAS)\, chromatin accessibility\, epigenome\, adipose tissue\, adipocyte.
URL:https://rna.umich.edu/events/karen-mohlke/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Detroit:20230130T160000
DTEND;TZID=America/Detroit:20230130T170000
DTSTAMP:20260403T155120
CREATED:20221102T121834Z
LAST-MODIFIED:20230110T144621Z
UID:10666-1675094400-1675098000@rna.umich.edu
SUMMARY:RNA Innovation Seminar: Carlos Cruchaga\,  Washington University in St Louis
DESCRIPTION:“Role of Circular RNA in Alzheimer’s Disease”\nCarlos Cruchaga\, Ph.D.\nDirector\, NeuroGenomics and Informatics Center\nWashington University in St Louis\nIn-person: BSRB\, ABC seminar rooms / hybrid link \nShort Bio: Dr. Cruchaga is a human genomicist with expertise in multiomics\, informatics\, and neurodegeneration. He completed his PhD in Biochemistry & Molecular Biology in 2005 at the University of Navarra in Spain. During his first postdoc with Dr. Pastor he conducted statistical human genetics studies focused on Alzheimer’s disease (AD) and Parkinson’s disease (PD). He then moved to Dr. Goate’s Lab to complete his training in quantitative human genomics. Dr Cruchaga established his laboratory at Washington University in  2011 to study the genetic architecture of neurodegenerative diseases. His interests are focused on using human genomic and other -omis data (proteomics\, metabolomics\, & lipidomics) to identify and understand the biological processes that lead to AD\, PD\, frontotemporal dementia\, and other neurodegenerative processes. He is the founding director of the NeuroGenomics and Informatics Center at Washington University. \nAbstract: Circular RNAs (circRNAs) are a class of RNAs highly expressed in the nervous system and enriched in synaptoneurosomes. In Alzheimer Disease\, synapse lost is one of the events implicated on disease. circRNA are form by back-splicing (head-to-tail splicing)\, and where first described in eukaryotic cells and other studies suggested that synapse could be enriched for circRNA. Based on we hypothesized that specific circRNA would be differentially expressed in AD cases compared to controls and that those effects could be detected early in the disease. We optimized and validated a novel analyses pipeline for circular RNAs (circRNA). We performed a three-stage study design to robustly identify circRNA associated with AD and AD-related phenotypes. Additional analyses were performed to demonstrate that the expression of circRNA were independent of the lineal form as well as the cell proportion that can confound results. Co-expression analyses of all the circRNA together with the lineal forms and found that circRNA\, including those that were differentially expressed in Alzheimer disease compared to controls co-expressed with known causal Alzheimer genes\, such as APP and PSEN1\, indicating that some circRNA are also part of the causal pathway. We also demonstrated that cirRNAs brain expression explained more about Alzheimer clinical manifestations that the number of APOε4 alleles\, suggesting that could be used as a potential biomarker for Alzheimer disease. In summary\, we demonstrated for the first time that brain circular RNAs (circRNA) are part of the pathogenic events that lead to Alzheimer’s disease
URL:https://rna.umich.edu/events/carlos-cruchaga/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Detroit:20230213T120000
DTEND;TZID=America/Detroit:20230213T130000
DTSTAMP:20260403T155120
CREATED:20221102T123120Z
LAST-MODIFIED:20230127T141731Z
UID:10670-1676289600-1676293200@rna.umich.edu
SUMMARY:RNA Innovation Seminar: Gal Haimovich\, Weizmann Institute of Science
DESCRIPTION:“Why Did the RNA Cross the Nanotube? Many questions and (some) answers on tunneling-nanotube medicated RNA transfer between mammalian cells”\nGal Haimovich\, Ph.D. \nAssistant Staff Scientist\nDepartment of Molecular Genetics\nWeizmann Institute of Science\nVirtual only: zoom link \nAbstract: RNAs have been shown to undergo transfer between mammalian cells\, though the mechanism behind this phenomenon and its overall importance to cell physiology is not well understood. We found that full-length mRNAs and lncRNAs undergo direct cell-cell transfer via cytoplasmic extensions called tunneling nanotubes (TNTs)\, which connect donor and acceptor cells. Despite 10 years of research\, there are still major questions about this process such as which RNAs are transferred\, what is the mechanism\, how is this process regulated and what does the RNA do on the other side? I will review the evidence for TNT-mediated RNA transfer\, discuss the technical challenges in this field\, and provide some answers to these questions.
URL:https://rna.umich.edu/events/gal-haimovich/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Detroit:20230227T160000
DTEND;TZID=America/Detroit:20230227T170000
DTSTAMP:20260403T155120
CREATED:20221102T124955Z
LAST-MODIFIED:20230227T210355Z
UID:10674-1677513600-1677517200@rna.umich.edu
SUMMARY:RNA Innovation Seminar: Jane Jackman\, Ohio State University
DESCRIPTION:“A Complicated Family: Conserved & Distinct Functions of tRNA Methyltransferases from Yeast to Humans”\nJane Jackman\, Ph.D.\nProfessor of Chemistry & Biochemistry\nOhio State University\nIn-person: BSRB\, ABC seminar rooms / zoom link \nAbstract: RNA modifications are now known to be a ubiquitous and important feature of cellular RNAs. tRNA are among the most heavily modified of RNA species\, with a large network of often highly conserved enzymes dedicated to introducing distinct modifications into specific subsets of tRNAs in each organism. The expanding number of technological approaches to mapping tRNA modifications has enabled an explosion of information about the types and locations of modifications in many biological systems\, but functional information about many modifications has lagged. The tRNA methyltransferase Trm10 is a SPOUT family RNA methyltransferase that is absolutely conserved throughout Archaea and Eukarya\, but exhibits markedly different substrate specificities for nucleotide and tRNA substrates in different biological contexts. However\, the molecular basis for these distinct substrate specificities has not been demonstrated. Moreover\, despite multiple phenotypes associated with loss of Trm10 N1-methylation\, including a role in human disease\, the biological impact of Trm10 modification is not understood. We have taken a comprehensive approach utilizing enzymes from diverse organisms from Archaea to humans and multiple eukaryotic model systems to identify conserved and unique mechanistic and functional features of this essential family of tRNA methyltransferases.
URL:https://rna.umich.edu/events/jane-jackman/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Detroit:20230306T160000
DTEND;TZID=America/Detroit:20230306T160000
DTSTAMP:20260403T155120
CREATED:20221202T145321Z
LAST-MODIFIED:20230228T162213Z
UID:10717-1678118400-1678118400@rna.umich.edu
SUMMARY:RNA Innovation Seminar: Lori Isom\, Chair\, Department of Pharmacology
DESCRIPTION:“Dancing to a Different Tune: TANGO Provides Hope for Dravet Syndrome”\nLori Isom\, Ph.D.\nChair\, Department of Pharmacology\nMaurice H. Seevers Collegiate Professor of Pharmacology\nProfessor of Molecular and Integrative Physiology\nProfessor of Neurology\, University of Michigan Medical School\nIn-person: BSRB\, ABC seminar rooms / zoom link \nAbstract: Dravet syndrome (DS) is a severe developmental and epileptic encephalopathy characterized by high seizure frequency and severity\, intellectual disability\, and a high risk of sudden unexpected death in epilepsy (SUDEP). Most DS patients carry de novo variants in SCN1A leading to haploinsufficiency of the voltage-gated sodium channel a subunit Nav1.1. Scn1a +/-  DS mouse models recapitulate many patient phenotypes\, including severe seizures and SUDEP. DS mice have reduced excitability of parvalbumin-positive (PV+) fast-spiking interneurons\, leading to disinhibition. Targeted Augmentation of Nuclear Gene Output (TANGO) was developed by our collaborators at Stoke Therapeutics to increase protein expression in diseases of haploinsufficiency using antisense oligonucleotide (ASO) technology. TANGO targets naturally occurring\, non-productive alternative splicing events to reduce non-productive mRNA and increase productive mRNA and protein of the target gene by upregulating the wild-type allele. This approach has provided a unique opportunity to develop novel therapeutics to treat DS. We showed previously that a single\, intracerebroventricular (ICV) dose at postnatal day (P)2 of the ASO STK-001\, generated using TANGO technology to prevent inclusion of a nonsense-mediated decay or poison exon in Scn1a\, exon 20N\, increased productive Scn1a transcript and Nav1.1 expression and reduced the incidence of electrographic seizures and SUDEP in a mouse model of DS (SCIENCE TRANSLATIONAL MEDICINE\, 2020\, Vol 12\, Issue 558\, DOI: 10.1126/scitranslmed.aaz6100). Interestingly\, de novo variants in SCN1A exon 20N were shown by others to increase its inclusion\, resulting in haploinsufficiency and DS pathology in patients and in a mouse model. Our preclinical work led to a series of on-going clinical trials for STK-001. Here\, we investigated the mechanism of a surrogate ASO that also targets exon 20N\, ST-1001\, in DS mouse brain. We tested the effects of a single ICV injection of ST-1001 at P2 on the subsequent electrophysiological properties of cortical pyramidal and PV+ fast-spiking interneurons in Scn1a +/- DS and Scn1a +/+ wild-type littermate control mice at P21-25. We show that\, in untreated DS mice\, intrinsic action potential (AP) firing properties of cortical pyramidal neurons were unchanged compared to controls while AP firing properties of PV+ interneurons showed depolarization block. In addition\, sodium current density was reduced in DS PV+ interneurons. The frequency\, but not amplitude\, of inhibitory post-synaptic currents recorded in DS cortical pyramidal neurons was also reduced\, suggesting reduced GABA release from interneurons. Single-dose ST-1001 ASO administration restored excitability and sodium current density in PV+ DS interneurons as well as restored GABAergic signaling to cortical pyramidal neurons. This new work provides key mechanisms for further development of precision medicine approaches to treat patients with DS and related developmental and epileptic encephalopathies. Our next experimental plan will include testing ST-1001 in a newly developed CRISPR transgenic rabbit model of DS as well as in DS patient-derived induced pluripotent stem cell neurons.
URL:https://rna.umich.edu/events/lori-isom/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Detroit:20230410T160000
DTEND;TZID=America/Detroit:20230410T170000
DTSTAMP:20260403T155120
CREATED:20221202T150015Z
LAST-MODIFIED:20230403T161646Z
UID:10721-1681142400-1681146000@rna.umich.edu
SUMMARY:RNA Innovation Seminar: Haiyuan Yu\, Cornell University
DESCRIPTION:“Dissect Enhancer Architecture and Map Regulatory Genomic Landscape Across Diverse Cell and Tissue Types Through Nascent Transcriptome Studies”\nHaiyuan Yu\, Ph.D.\nTisch University Professor\nDepartment of Biological Statistics and Computational Biology\nWeill Institute for Cell and Molecular Biology\nDirector\, Center for Innovative Proteomics (CIP@Cornell)\nIn-person: BSRB\, ABC seminar rooms / hybrid link \nAbstract: Recent studies have shown that both enhancers and promoters can recruit RNA pol II and initiate transcription. The short half-life nature of enhancer RNAs (eRNAs) makes detection of distal initiation events challenging. Through systematic comparison of RNA sequencing assays\, we find that nascent transcriptome assays\, PRO-cap and PRO-seq\, have great sensitivity and specificity in detecting eRNA transcription genome-wide. In fact\, we find that\, unlike histone marks\, divergent transcription of eRNAs is a critical mark for all active enhancers genome-wide. Moreover\, nascent transcription precisely delineates the sequence architecture of enhancers\, whereby transcription start sites (TSSs) serve as critical anchors in revealing motif positioning within enhancers and their boundaries. By leveraging our high precision and sensitivity nascent transcriptome PRO-cap and PRO-seq assays\, we mapped the active transcriptional regulatory landscape across ~200 tissue and cell types of the human body with unprecedented resolution and depth. This information is used to quantify gene transcriptional activity and to identify and delineate transcription regulatory elements\, including both enhancers and promoters that are cell-type-specific and ubiquitous. These findings are critical in modeling putative enhancer-promoter connectivity and in speeding the identification of potential disease-associated noncoding variants in regulatory regions.
URL:https://rna.umich.edu/events/haiyuan-yu/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Detroit:20230417T160000
DTEND;TZID=America/Detroit:20230417T170000
DTSTAMP:20260403T155120
CREATED:20221202T153751Z
LAST-MODIFIED:20230410T185444Z
UID:10725-1681747200-1681750800@rna.umich.edu
SUMMARY:RNA Innovation Seminar: Julius B. Lucks\, Northwestern University
DESCRIPTION:“RNA Synthetic Biology: Towards an Era of RNA Design for Biology & Global Health”\nJulius B. Lucks\, Ph.D.\nProfessor & Associate Chair\, Chemical & Biological Engineering\nCo-Director\, Center for Synthetic Biology\nNorthwestern University\nIn-person: BSRB\, ABC seminar rooms / hybrid link \nAbstract: RNAs are emerging as a powerful substrate for engineering cellular behavior. As with all biomolecules\, RNA function is intimately related to its structure\, since RNA can adopt structures that selectively modulate gene expression. Central questions in biology & bioengineering then are: How do RNAs fold inside cells?; and How can we engineer these folds to control gene expression? In this talk\, I will present our work at the interface of these two questions and share results that are beginning to uncover design principles for understanding natural RNAs and engineering RNAs for an array of applications in biomanufacturing and human health. I will focus on our recent work in understanding how riboswitch RNAs make regulatory decisions “on the fly” during the process of transcription\, how we can use riboswitches as biosensors\, and our recent development of a new synthetic biology biosensing platform that allows rapid\, field-deployable diagnostics for a range of compounds important to our health and the environment. \nRNA\, RNA folding\, RNA synthetic biology\, Riboswitches\, Cell-Free Synthetic Biology
URL:https://rna.umich.edu/events/julius-b-lucks/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Detroit:20230515T160000
DTEND;TZID=America/Detroit:20230515T170000
DTSTAMP:20260403T155120
CREATED:20221202T155738Z
LAST-MODIFIED:20230509T124553Z
UID:10732-1684166400-1684170000@rna.umich.edu
SUMMARY:RNA Innovation Seminar: Eric Wang\, University of Florida
DESCRIPTION:“Repeat Expansions Instigate Supply Chain Issues in the Nucleus & Cytoplasm”\nEric Wang\, Ph.D.\nAssociate Professor\nMolecular Genetics & Microbiology\nCenter for Neurogenetics\nUniversity of Florida\nIn-person: BSRB\, ABC seminar rooms / hybrid link \nKeywords: Repeat expansions\, myotonic dystrophy\, RNA biology\, RNA splicing\, RNA localization\, microscopy
URL:https://rna.umich.edu/events/eric-wang/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Detroit:20230605T160000
DTEND;TZID=America/Detroit:20230605T160000
DTSTAMP:20260403T155120
CREATED:20221202T154626Z
LAST-MODIFIED:20230504T153611Z
UID:10728-1685980800-1685980800@rna.umich.edu
SUMMARY:RNA Innovation Seminar: Lydia Contreras\, UT Austin
DESCRIPTION:“Mapping Novel RNA Regulatory Networks”\nLydia Contreras\, Ph.D.\nProfessor-Chemical Engineering\nInterdisciplinary Life Science Graduate Program\nUniversity of Texas at Austin\n  \nIn-person: BSRB ABC Seminar Rooms / hybrid link \nAbstract: While advances in omics-based technologies has led to the discovery of hundreds of sRNAs\, their identification and characterization has lagged. Even in the model gram-negative organism\, Escherichia coli\, only ~40% and 60% of sRNAs have had at least one transcriptional regulator or post-transcriptional target confirmed\, respectively. Additionally\, the mechanistic roles of RNA-binding proteins in sRNA regulation remains elusive. This gap can be partly attributed to the selective nature of corresponding high-throughput techniques that typically rely on traditional sRNA features\, such as basic promoter-based transcriptional regulation and dependence on RNA binding proteins for target activity. Additionally\, lowly expressed sRNAs in commonly tested conditions are oftentimes missed. To better characterize these non-traditional and elusive sRNAs\, we devised a holistic multi-tiered approach using in vivo omics datasets over a variety of cellular conditions. In this talk\, we will describe our recent advances in developing high throughput approaches that allow for the simultaneous in vivo characterization of functional regions within RNA molecules. We will describe how RNA insights obtained from these synthetic probing approach can be used in the basic characterization of newly discovered RNAs and in the discovery of novel RNA mechanisms. The talk will also highlight our use of these methods in conjunction with new biophysical model and machine learning approaches for expanding our understanding of sRNA-regulation.
URL:https://rna.umich.edu/events/lydia-contreras/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Detroit:20230619T160000
DTEND;TZID=America/Detroit:20230619T170000
DTSTAMP:20260403T155120
CREATED:20221202T160624Z
LAST-MODIFIED:20230606T191750Z
UID:10735-1687190400-1687194000@rna.umich.edu
SUMMARY:RNA Innovation Seminar: Junjie Guo\, Yale University School of Medicine
DESCRIPTION:RNA Plasticity in Neuronal Health & Disease\nJunjie Guo\, Ph.D.\nAssistant Professor\nDepartment of Neuroscience\nYale University School of Medicine\nIn-person: BSRB\, ABC seminar rooms / hybrid link \nAbstract: Spatial and temporal regulation of gene expression at both transcriptional and post-transcriptional levels underlies the development and functions of the nervous system\, whereas dysregulated gene expression is often implicated in neurological disorders. My lab has been interested in the roles of post-transcriptional mRNA regulation in diversifying the functional output of neuronal gene expression. In this talk\, I will discuss our ongoing work on understanding the pathophysiological mechanisms by which disease-associated nucleotide repeat expansion disrupt neuronal health. I will also discuss our new work on the unexpected plasticity of N-terminal signal sequences and the role of alternative mRNA translation initiation in tuning this plasticity. \nKeywords: RNA processing\, mRNA translation\, signal sequence\, synapse\, neurodegeneration
URL:https://rna.umich.edu/events/junjie-guo/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Detroit:20230911T160000
DTEND;TZID=America/Detroit:20230911T170000
DTSTAMP:20260403T155120
CREATED:20230801T151536Z
LAST-MODIFIED:20230825T170313Z
UID:11196-1694448000-1694451600@rna.umich.edu
SUMMARY:RNA Innovation Seminar: Graham Erwin\, Stanford University
DESCRIPTION:“Discovering and Targeting Repeat Expansions in Human Disease”\nGraham Erwin\, Ph.D.\nStanford Cancer Institute Postdoctoral Fellow\nDepartment of Genetics\nStanford University \n  \n  \nIn-person: BSRB\, ABC seminar rooms / hybrid link \nAbstract: Expansion of a single repetitive DNA sequence\, termed a tandem repeat (TR)\, is known to cause more than 50 diseases. However\, repeat expansions are often not explored beyond neurological and neurodegenerative disorders. Here\, I will discuss efforts to identify and target repeat expansions in human disease\, with a focus on neurodegenerative disease and cancer.
URL:https://rna.umich.edu/events/graham-erwin/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Detroit:20230913T110000
DTEND;TZID=America/Detroit:20230913T140000
DTSTAMP:20260403T155120
CREATED:20230911T195120Z
LAST-MODIFIED:20230911T195351Z
UID:11576-1694602800-1694613600@rna.umich.edu
SUMMARY:Researchpalooza
DESCRIPTION:Stop by the CRB booth (#1) and the SMART Center (#2) on September 13 at the Researchpalooza event!
URL:https://rna.umich.edu/events/researchpalooza/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Detroit:20230925T160000
DTEND;TZID=America/Detroit:20230925T170000
DTSTAMP:20260403T155120
CREATED:20230801T154411Z
LAST-MODIFIED:20230922T220005Z
UID:11203-1695657600-1695661200@rna.umich.edu
SUMMARY:RNA Innovation Seminar: Jeffrey Barrick\, UT at Austin
DESCRIPTION:“Turning Bugs into Features: Engineering and Evolving Insect Symbiont-Mediated RNA Interference”\nJeffrey Barrick\, Ph.D.\nAssociate Professor of Molecular Biosciences\nUniversity of Texas at Austin \n  \n  \nIn-person: BSRB\, ABC seminar rooms / hybrid link \nAbstract: Many insects have co-evolved associations with microbial symbionts that are more consequential than our relationship with the human microbiome. These symbionts may live within insect cells\, be inherited across generations\, and support host survival. My research group and our collaborators have developed genetic toolkits for engineering diverse bacterial symbionts associated with flies\, aphids\, bees\, and other insects. Because of their important and integrated functions\, engineered symbionts can be used to study insect biology\, protect beneficial insects\, and prevent pests from vectoring disease. Recently\, we have examined how culturable “protosymbiont” strains of Serratia symbiotica colonize aphids and demonstrated that they are transmitted to offspring. We are now attempting to attenuate the pathogenicity of these strains to initiate new stable symbioses. In other work\, we have shown that the honey bee gut symbiont Snodgrassella alvi can be engineered to express double-stranded RNAs that induce a targeted RNA interference response in their hosts. These engineered symbionts can be used to knock down expression of bee genes as a tool for functional genomics. We have also used double-stranded RNA expression by symbionts to prime the bee immune system against viral infection and induce a self-killing response in parasitic Varroa mites that feed on bees in order to protect pollinator health.
URL:https://rna.umich.edu/events/jeffrey-barrick/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Detroit:20230927T180000
DTEND;TZID=America/Detroit:20230927T210000
DTSTAMP:20260403T155120
CREATED:20230802T145829Z
LAST-MODIFIED:20230822T162119Z
UID:11270-1695837600-1695848400@rna.umich.edu
SUMMARY:"Awakenings" Film Screening and Panel Discussion at the Michigan Theater
DESCRIPTION:“Awakenings” (1990) \nThe victims of an encephalitis epidemic many years ago have been catatonic ever since\, but now a new drug offers the prospect of reviving them.  \nJoin us for a pre-film panel discussion at 6:00 PM with neurology and neurologic disease physicians and scientists from University of Michigan’s Center for RNA Biomedicine: Michelle Hastings\, Ph.D.; Maria G. Castro\, Ph.D.; Christiane Wobus\, Ph.D.; Henry Paulson\, M.D.\, Ph.D.; Peter Todd\, M.D.\, Ph.D.; and moderated by Nils G. Walter\, Ph.D. \n\n\n\nFilm screening will begin at 7:00 PM. The story of a doctor’s extraordinary work in the Sixties with a group of catatonic patients he finds languishing in a Bronx hospital. Speculating that their rigidity may be akin to an extreme form of Parkinsonism\, he seeks permission from his skeptical superiors to treat them with L-dopa\, a drug that was used to treat Parkinson’s disease at the time. From director Penny Marshall and starring Robert De Niro and Robin Williams. \n121 minutes. Drama. PG-13. \n$10.50 General | $8.50 Students\, Seniors\, U.S. Veterans | $8 MTF Members \n\n \n\nPresented with the University of Michigan Center for RNA Biomedicine\, Michigan Medicine and Michigan Theater Foundation
URL:https://rna.umich.edu/events/awakenings-film-screening-and-panel-discussion-at-the-michigan-theatre/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Detroit:20231009T160000
DTEND;TZID=America/Detroit:20231009T170000
DTSTAMP:20260403T155120
CREATED:20230810T130356Z
LAST-MODIFIED:20230925T172352Z
UID:11375-1696867200-1696870800@rna.umich.edu
SUMMARY:RNA Innovation Seminar: Guizhi (Julian) Zhu\, University of Michigan
DESCRIPTION:“Engineer and deliver nucleic acid immunotherapeutics and vaccines – a focus on small circular mRNA (circRNA) vaccines”\nGuizhi (Julian) Zhu\, Ph.D.\nAra G. Paul Associate Professor of Pharmaceutical Science\nUniversity of Michigan \n  \nIn-person: BSRB\, ABC Seminar Rooms / hybrid link \nAbstract: Our ultimate research goal is to develop clinically translatable nucleic acid therapeutics and vaccines\, along with their delivery systems. In this talk\, we will mainly discuss small circular mRNA (circRNA) vaccines for cancer immunotherapy and the prevention of infectious diseases. Modification-free small circRNA vaccines are highly stable and sequence-defined with unique innate immunomodulatory mechanisms and sustained production of concatemeric antigens\, resulting in robust and long-lasting adaptive immunity. Relative to several state-of-the-art modified mRNAs\, nanocarrier-delivered circRNA vaccines elicited up to 10-fold antigen-specific T cells in mice\, with superior T cell memory and vaccine safety. circRNA vaccines are widely applicable for tumor and viral (neo)antigens to elicit potent and long-lasting CD8+/CD4+ T cell responses in young or immunosenescent aged mice. Combining circRNA vaccines with immune checkpoint blockade (ICB) reduced tumor immunosuppression and eradicated multiple types of murine tumors\, including ICB-resistant BrafV600E melanoma. Moreover\, pulmonary delivery of influenza circRNA vaccines protected mice from influenza challenge. Overall\, small circRNA vaccines are promising for versatile applications. Lastly\, we will also briefly discuss our research in cGAS-STING- and ADAR1- related nucleic acid therapeutics and drug delivery systems for cancer and autoimmune diseases.
URL:https://rna.umich.edu/events/guizhi-julian-zhu/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Detroit:20231023T160000
DTEND;TZID=America/Detroit:20231023T170000
DTSTAMP:20260403T155120
CREATED:20230801T164121Z
LAST-MODIFIED:20231010T174315Z
UID:11208-1698076800-1698080400@rna.umich.edu
SUMMARY:RNA Innovation Seminar: Susan Gottesman\, NIH/NCI
DESCRIPTION:“Bacterial Small RNAs: Regulatory Circuits\, On & Off Switches\, & Quality Control”\nSusan Gottesman\, Ph.D.\nChief\, Laboratory of Molecular Biology\nNIH/NCI Distinguished Investigator \n  \n  \nIn-person: BSRB\, ABC Seminar Rooms / hybrid link \nAbstract: Bacteria use small regulatory RNAs (sRNAs) and the RNA chaperone Hfq to regulate mRNA translation and stability\, akin to miRNAs and the RISC complex in eukaryotes. The approaches to defining bacterial sRNAs and their targets have dramatically improved since the screens that first identified many of them over 20 years ago. Current tools provide a global view of Hfq-binding RNAs that suggests increasingly interwoven regulatory networks\, helping cell respond appropriately to stress and host interactions. On-switches for sRNAs are primarily at the level of transcription; when transcription ceases\, most of the sRNAs are used stoichiometrically\, being degraded as they are used\, providing an effective Off-switch for sRNA regulation. We have used genetic screens to identify novel regulators of both Hfq and the sRNAs. One of these\, HqbA\, binds directly to the distal face of Hfq\, and competes with weakly binding RNAs for association with Hfq\, suggesting it is a new quality control regulator for Hfq. Data suggests that this is a bifunctional protein\, directly regulating Hfq by protein-protein interaction and regulating other processes independently of Hfq. HqbA\, along with other factors\, help to ensure appropriate hierarchy of sRNA function. \nKeywords: mRNA translation; RNAse E; Escherichia coli.
URL:https://rna.umich.edu/events/susan-gottesman/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Detroit:20231106T160000
DTEND;TZID=America/Detroit:20231106T170000
DTSTAMP:20260403T155120
CREATED:20230801T164453Z
LAST-MODIFIED:20231024T140916Z
UID:11211-1699286400-1699290000@rna.umich.edu
SUMMARY:RNA Innovation Seminar: Irina Artsimovitch\, Ohio State University
DESCRIPTION:“Locking Rho up”\nIrina Artsimovitch\, Ph.D.\nArts & Sciences Distinguished Professor\nDepartment of Microbiology\nThe Ohio State University \nIn-person: BSRB\, ABC seminar rooms / hybrid link \nAbstract: Bacterial termination factor Rho co-transcriptionally surveils the nascent RNA and releases damaged and junk transcripts from RNA polymerase. During rapid growth\, Rho maintains the transcriptome health\, but how is Rho activity modulated during dormancy or stress\, conditions prevalent in natural habitats? Rho is a hexameric RNA helicase that adopts active closed-ring and inactive open-ring states\, and the interconversion between these states is thought to be a key checkpoint in Rho control. I will discuss two mechanisms by which ligands that bind at Rho subunit interfaces restrain ring dynamics. The Sm-like Rof protein binds at the extended RNA-binding site of Rho\, occluding its RNA- and RNA polymerase-binding sites and locking the hexamer open.  The stress alarmone (p)ppGpp binds to the ATP-binding site and stabilizes the open ring\, triggering phase separation into inactive higher-order oligomers and extended filaments. These and other anti-termination mechanisms are expected to silence Rho under conditions when unrestrained termination would be lethal. \nKeywords: transcription; termination; Rho helicase; stress response; phase separation
URL:https://rna.umich.edu/events/irina-artsimovitch/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Detroit:20231120T160000
DTEND;TZID=America/Detroit:20231120T170000
DTSTAMP:20260403T155120
CREATED:20230801T170218Z
LAST-MODIFIED:20231030T193356Z
UID:11214-1700496000-1700499600@rna.umich.edu
SUMMARY:RNA Innovation Seminar: George Lisi\, Brown University
DESCRIPTION:“The Invisible Dance of CRISPR-Cas9 through Molecular Space and Time”\nGeorge Lisi\, Ph.D.\nThomas J. & Alice M. Tisch Assistant Professor\nDepartment of Molecular Biology\, Cell Biology & Biochemistry\nBrown University \n  \nIn-person: BSRB\, ABC seminar rooms / hybrid link \nAbstract: This talk will focus on long-range signaling in CRISPR-Cas9\, a cutting-edge genome editing tool. The transformative potential of Cas9 as a precision therapeutic cannot be realized without an understanding of its interdomain communication and the mitigation of deleterious off-target cleavage\, which is being characterized at the atomic level in the group. A series of vignettes will highlight NMR studies of Cas9 through a “divide-and-conquer” approach using engineered protein constructs and first demonstrate that multi-timescale motions in the catalytic nuclease of Cas9 propagates chemical information that regulates cleavage of double-stranded DNA. The talk will also highlight specificity-enhancing mutations in Cas9 that rewire its regulatory mechanism and RNA interactions at the molecular level to mitigate off-target DNA cleavage. Critical energetics of the mechanism will be discussed\, including the importance of metal ions and the protonation state of the catalytic histidine\, studied via catalytic pocket mutations that limit conformational sampling of the Cas9 active state. Lastly\, insight from canonical Cas9s will be expanded to highly stable thermophiles that are more promising for genome engineering and offer tunable high-temperature DNA editing and RNA binding. The underlying chemistry and atomic level dynamics of Cas9 will be linked to its nucleic acid interactions and biological outcomes\, hopefully opening new avenues for intuitive manipulation of its function and precision therapeutic properties.
URL:https://rna.umich.edu/events/george-lisi/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Detroit:20231204T160000
DTEND;TZID=America/Detroit:20231204T170000
DTSTAMP:20260403T155120
CREATED:20230801T170510Z
LAST-MODIFIED:20231120T174027Z
UID:11219-1701705600-1701709200@rna.umich.edu
SUMMARY:RNA Innovation Seminar: Andy Berglund\, University at Albany
DESCRIPTION:“Mis-splicing in repeat expansion diseases and development of potential therapeutics”\nAndy Berglund\, Ph.D.\nEmpire Professor of Innovation\nDirector of the RNA Institute\nUniversity at Albany \n  \nIn-person: BSRB\, ABC Seminar Rooms / hybrid link \nAbstract: Repeat or microsatellite expansions are responsible for more than 50 human diseases. Myotonic dystrophy (DM)\, amyotrophic lateral sclerosis (ALS)\, and spinocerebellar ataxias (SCAs) are a few examples of repeat expansion diseases. RNA processing (pre-mRNA splicing) pathways are negatively impacted in these diseases with specific changes in pre-mRNA splicing proposed to lead to symptoms observed in affected individuals. Many of the projects in the lab combine biochemical\, molecular\, and genomic approaches with cellular and other model systems to understand the mechanisms through which these diseases alter pre-mRNA splicing. Through screening approaches\, small molecules have been identified that reduce the levels of the repeat expansion RNAs and rescue mis-splicing in DM and SCA cell and animal models. \nKeywords: Myotonic Dystrophy\, Spinocerebellar Ataxias\, Alternative Splicing and RNA Binding Proteins
URL:https://rna.umich.edu/events/andy-berglund/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Detroit:20240122T160000
DTEND;TZID=America/Detroit:20240122T170000
DTSTAMP:20260403T155120
CREATED:20230810T175026Z
LAST-MODIFIED:20240118T171235Z
UID:11385-1705939200-1705942800@rna.umich.edu
SUMMARY:RNA Innovation Seminar: Anthony Rosenzweig\, University of Michigan
DESCRIPTION:“Noncoding RNA Targets in Heart Failure”\nAnthony Rosenzweig\, M.D.\nProfessor of Internal Medicine\nDirector of the MM Institute of Heart & Brain Health\nUniversity of Michigan \n  \n  \nIn-person: BSRB\, ABC seminar rooms / hybrid link \nAbstract: TBA
URL:https://rna.umich.edu/events/anthony-rosenzweig/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Detroit:20240205T160000
DTEND;TZID=America/Detroit:20240205T170000
DTSTAMP:20260403T155120
CREATED:20230801T171938Z
LAST-MODIFIED:20240125T125013Z
UID:11228-1707148800-1707152400@rna.umich.edu
SUMMARY:RNA Innovation Seminar: Sarah Woodson\, Johns Hopkins University 
DESCRIPTION:“How chaperones help RNAs choose the right partner”\nSarah Woodson\, Ph.D.\nT.C. Jenkins Professor of Biophysics\nJohns Hopkins University \n  \nIn-person: BSRB\, ABC seminar rooms / hybrid link \nAbstract: Non-coding RNAs must fold into specific structures to create the machinery for protein synthesis or to control gene expression.  As nascent transcripts can form different base pairing interactions\, finding the right partner can take time. RNA chaperone proteins increase the RNA dynamics\, enabling the kinetic selection of optimal RNA interactions. How a DEAD-box helicase improves the fidelity of ribosome assembly and how Hfq increases the selectivity of small RNA regulation will be discussed.
URL:https://rna.umich.edu/events/sarah-woodson/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Detroit:20240219T160000
DTEND;TZID=America/Detroit:20240219T170000
DTSTAMP:20260403T155120
CREATED:20231205T171219Z
LAST-MODIFIED:20240202T214715Z
UID:12721-1708358400-1708362000@rna.umich.edu
SUMMARY:RNA Innovation Seminar: Joan Steitz\, Yale University
DESCRIPTION:“RNA-RNA Base Pairing: Key to unlocking the functions of many noncoding RNAs”\nJoan Steitz\, Ph.D.\nSterling Professor of Molecular Biophysics and Biochemistry\nYale University \n  \nIn-person: BSRB\, ABC seminar rooms / hybrid link \nAbstract: Dr. Steitz’s talk will be primarily historical\, with many examples of discoveries of RNA-RNA base pairing over her 50-year+ career being reviewed. At the end\, she will mention her latest unpublished finding: how RNA-RNA-based pairing prevents neuronal death under stress conditions.
URL:https://rna.umich.edu/events/rna-innovation-seminar-joan-steitz/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Detroit:20240308T083000
DTEND;TZID=America/Detroit:20240308T170000
DTSTAMP:20260403T155120
CREATED:20230810T142049Z
LAST-MODIFIED:20231206T163253Z
UID:11380-1709886600-1709917200@rna.umich.edu
SUMMARY:8th Annual RNA Symposium
DESCRIPTION:“Unmasking the Power of RNA: From Structure to Medicine”\nFriday\, March 8\, 2024\, 8:30 am – 5:00 pm\nA. Alfred Taubman Biomedical Science Research Bldg\, Kahn Auditorium\n109 Zina Pitcher Pl\, Ann Arbor\, Michigan \nFor More Information and to Register\, Click Here.
URL:https://rna.umich.edu/events/8th-annual-rna-symposium/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Detroit:20240318T160000
DTEND;TZID=America/Detroit:20240318T170000
DTSTAMP:20260403T155120
CREATED:20230801T173457Z
LAST-MODIFIED:20240305T165938Z
UID:11233-1710777600-1710781200@rna.umich.edu
SUMMARY:RNA Innovation Seminar: Evgeny Nudler\, New York University
DESCRIPTION:“Transcription-driven DNA Repair”\nEvgeny Nudler\, Ph.D.\nJulie Wilson Anderson Professor of Biochemistry\nInvestigator\, Howard Hughes Medical Institute\nDepartment of Biochemistry & Molecular Pharmacology\nNYU Grossman School of Medicine \n  \nIn-person: BSRB\, ABC seminar rooms / hybrid link \nAbstract: Using E. coli as a model system\, we have developed new approaches to study damage recognition and processing in vivo for three major DNA repair pathways\, nucleotide excision repair (NER)\, ribonucleotide excision repair (RER)\, and base excision repair (BER). Our recent findings let us to formulate a conceptually new model of global transcription-driven repair (TDR)\, in which RNA polymerase serves as the indispensable genome-wide DNA damage sensor and also delivery vehicle and platform for the assembly of specialized repair complexes in living cells. The model provides a framework for better understanding genotoxic stress response and genome instability in bacteria and beyond.\nKeywords: DNA repair\, transcription elongation\, RNA polymerase\, ppGpp\, NER\, BER\, RER
URL:https://rna.umich.edu/events/evgeny-nudler/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Detroit:20240401T160000
DTEND;TZID=America/Detroit:20240401T170000
DTSTAMP:20260403T155120
CREATED:20230801T174241Z
LAST-MODIFIED:20240321T114711Z
UID:11237-1711987200-1711990800@rna.umich.edu
SUMMARY:RNA Innovation Seminar: Shuying Sun\, Johns Hopkins University
DESCRIPTION:“RNA Metabolism in C9ORF72-linked neurodegenerative diseases ALS and FTD”\nShuying Sun\, Ph.D.\nAssociate Professor\, Department of Physiology\nBrain Science Institute\nJohns Hopkins University School of Medicine \n  \nIn-person: BSRB\, ABC seminar rooms / hybrid link \nAbstract: We have a long-standing interest in RNA metabolism dysfunction and RNA-targeting therapy in neurodegenerative diseases\, particularly amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The hexanucleotide GGGGCC repeat expansion in C9ORF72 is the most frequent genetic cause of both ALS and FTD. RNA-mediated gain of toxicity is critical for the pathogenesis. We employ multiple molecular approaches to understand the regulation of the repeat RNA processing\, uncover genetic modifiers\, and elucidate the influence on global RNA metabolism. We aim to understand the disease mechanisms and identify potential therapeutic targets for C9ORF72-ALS/FTD.
URL:https://rna.umich.edu/events/shuying-sun/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Detroit:20240506T160000
DTEND;TZID=America/Detroit:20240506T170000
DTSTAMP:20260403T155120
CREATED:20230811T164358Z
LAST-MODIFIED:20240506T133417Z
UID:11390-1715011200-1715014800@rna.umich.edu
SUMMARY:**CANCELED** RNA Innovation Seminar: Catherine Kaczorowski\, University of Michigan
DESCRIPTION:**CANCELED**\nDue to unforeseen circumstances\, today’s RNA Innovation seminar featuring Dr. Catherine Kaczorowski has been canceled. Please be on the lookout for rescheduling information in the coming days \n“Using Complex Genetics in Mice to Unlock the Secrets of Cognitive Resilience”\nCatherine Kaczorowski\, Ph.D.\nElinor Levine Professor of Dementia Research\nProfessor of Neurology\nUniversity of Michigan\, Medical School \nIn-person: BSRB\, ABC Seminar Room / hybrid link \nAbstract: Alzheimer’s Disease\, Systems Genetics\, Resilience
URL:https://rna.umich.edu/events/catherine-kaczorowski/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Detroit:20240603T160000
DTEND;TZID=America/Detroit:20240603T170000
DTSTAMP:20260403T155120
CREATED:20230816T143558Z
LAST-MODIFIED:20240529T125952Z
UID:11411-1717430400-1717434000@rna.umich.edu
SUMMARY:RNA Innovation Seminar: Alexandra Piotrowski-Daspit\, Internal Medicine
DESCRIPTION:“RNA: the delivery perspective”\nAlexandra Piotrowski-Daspit\, Ph.D.\nAssistant Professor\, Biomedical Engineering\nAssistant Professor\, Internal Medicine – Pulmonary & Critical Care Medicine Division\nUniversity of Michigan \n  \nIn-person: BSRB\, Kahn Auditorium / hybrid link \nAbstract: The primary barrier for clinical translation of RNA therapeutics remains delivery to target tissues in vivo. Upon entering the body\, delivery vehicles encounter extracellular and intracellular barriers. It is also unclear how carrier design features impact physiological interactions with biological systems\, highlighting the need for studies that elucidate these structure-function relationships. In this seminar\, I will describe our work on developing polymeric nanoparticles (NPs) to deliver therapeutic RNAs to a variety of tissues following local and systemic IV administration. We find that gene therapy can be significantly enhanced using a new class of polymeric vehicles consisting of poly(amine-co-ester) (PACE) polymers that are designed for safe and effective nucleic acid delivery. We have also developed tools to study nanomaterial-biology interactions in animal models\, including a high-throughput quantitative microscopy-based platform to measure circulation half-life and biodistribution in vivo. This tool\, alongside the development of novel polymeric carriers\, can be used to study the structure-function relationships that guide the physiological fate of NPs in order to rationally design more effective delivery vehicles for RNA delivery. \nKeywords: RNA therapeutics\, in vivo delivery\, polymeric nanoparticles (NPs)\, nanomaterial-biology interactions
URL:https://rna.umich.edu/events/alexandra-piotrowski-daspit/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Detroit:20240912T090000
DTEND;TZID=America/Detroit:20240912T123000
DTSTAMP:20260403T155120
CREATED:20240904T135915Z
LAST-MODIFIED:20240904T135915Z
UID:15226-1726131600-1726144200@rna.umich.edu
SUMMARY:David R. Walt\, Ph.D. — Special Lecture and Open House Breakfast
DESCRIPTION:The Center for RNA Biomedicine presents microwell array pioneer\, David R. Walt\, PH.D.\n \nOn Thursday\, September 12\, the Center for RNA Biomedicine will host life sciences industry expert David R. Walt\, Ph.D. for a special lecture titled\, “Why sensitivity matters for clinical diagnosis (see abstract below).” \nFollowing the lecture\, there will be an open house breakfast with opportunities to socialize with peers and connect with Dr. Walt. \nSchedule — Thursday\, September 12 | 9 a.m. – 12:30 p.m.\n9 a.m. – 10:15 a.m. | David Walt\, Ph.D. Lecture — Koessler Room\, 3rd Floor\, Michigan League\n10:30 a.m. – 12:30 p.m. | Open House Breakfast with Dr. Walt — Henderson Room (directly across from Koessler)\, 3rd Floor\, Michigan League\n**A hybrid option is being offered via Zoom — click here to register.** \nWhether in person or virtual\, we hope you’ll join us for learning\, coffee\, and socializing with one of the top minds in fields of bio-inspired engineering\, RNA-based clinical diagnosis\, and life sciences startups. \nAbstract and Speaker Info\nAbstract:\nA major challenge for many clinical diagnostic applications is the quantification of low-abundance proteins and other biomolecules in biological fluids. For example\, traditional techniques\, such as enzyme-linked immunosorbent assay (ELISA)\, can only measure several hundred proteins in human blood\, which is limiting because there are thousands of proteins present at low concentrations that are of potential diagnostic utility. Single-molecule technologies allow for digital counting of individual protein molecules and have enabled 1000-fold increases in sensitivity over conventional protein detection methods. We have pioneered the development of these technologies that provide for multiplexed measurements with femtomolar sensitivities or below. I will discuss the technologies and describe their application to neurodegenerative disease\, cancer\, and infectious diseases. \nAbout David R. Walt\, Ph.D.:\nDavid R. Walt is the Hansjörg Wyss Professor of Bioinspired Engineering at Harvard Medical School\, Professor of Pathology at Brigham and Women’s Hospital and Harvard Medical School\, Core Faculty Member of the Wyss Institute at Harvard University\, Associate Member at the Broad Institute\, and is a Howard Hughes Medical Institute Professor. His lab’s research focuses on creating and using novel technologies to solve unmet clinical diagnostics problems. Walt is the Scientific Founder of Illumina Inc.\, Quanterix Corp.\, and has co-founded multiple other life sciences startups including Ultivue\, Inc.\, Arbor Biotechnologies\, Sherlock Biosciences\, Vizgen\, Inc.\, and Protillion Biosciences. He has received numerous national and international awards and honors for his fundamental and applied work in the field of optical microwell arrays and single molecules including the 2023 National Academy of Engineering’s Fritz J. and Dolores H. Russ Prize and the 2021 Kabiller Prize in Nanoscience and Nanomedicine. He is a member of the U.S. National Academy of Engineering\, the U.S. National Academy of Medicine\, a Member of the American Philosophical Society\, a Fellow of the American Academy of Arts and Sciences\, a Fellow of the American Institute for Medical and Biological Engineering\, a Fellow of the American Association for the Advancement of Science\, a Fellow of the National Academy of Inventors\, and is inducted in the US National Inventors Hall of Fame. \n 
URL:https://rna.umich.edu/events/david-r-walt-ph-d-special-lecture-and-open-house-breakfast/
LOCATION:Michigan League\, 911 N University\, Ann Arbor\, MI\, 48109\, United States
END:VEVENT
END:VCALENDAR